NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 92 filers reported holding NUVALENT INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,021,132 | +2.6% | 22,213 | -5.9% | 0.00% | – |
| Q2 2023 | $995,718 | +154.0% | 23,612 | +57.2% | 0.00% | – |
| Q1 2023 | $391,950 | +39095.0% | 15,023 | +27720.4% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 54 | -67.1% | 0.00% | – |
| Q2 2022 | $2,000 | -96.6% | 164 | -96.1% | 0.00% | – |
| Q1 2022 | $59,000 | -49.6% | 4,229 | -31.6% | 0.00% | – |
| Q4 2021 | $117,000 | +11600.0% | 6,182 | +11348.1% | 0.00% | – |
| Q3 2021 | $1,000 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $918,987,373 | 20.25% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $164,446,964 | 18.39% |
| Fairmount Funds Management LLC | 2,451,819 | $112,710,119 | 13.56% |
| Paradigm Biocapital Advisors LP | 1,638,147 | $75,305,618 | 5.11% |
| COMMODORE CAPITAL LP | 828,778 | $38,098,925 | 4.45% |
| Perceptive Advisors | 2,463,451 | $113,244,842 | 3.78% |
| Boxer Capital, LLC | 1,210,192 | $55,632,526 | 2.96% |
| Tri Locum Partners LP | 113,528 | $5,218,882 | 1.67% |
| Ikarian Capital, LLC | 278,034 | $12,781,224 | 1.54% |
| Ikarian Capital, LLC | 2,395 | $11,009,815 | 1.32% |